Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors
조합 AAV/RNAi 발현 벡터를 사용한 SARS-CoV-2의 생체외 및 생체내 억제
Article
Published on
Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 변종, 치료제,
Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 변종, 치료제,
[키워드] AAV
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
adeno-associated virus
Antiviral
Antiviral agents
antiviral RNAi
Cell
clinically
cocktail
complement
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
disease symptom
effective
escape mutant
escape mutants
experiment
expression vector
flexible
Genetic
global effort
Gut
hACE2
in vivo
infected cell
infected cells
intestinal cells
intranasal
mice
mutational escape.
N gene
N genes
organoids
pandemic
prevented
RdRP
RNA
RNAi
SARS virus
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 RdRp
SARS-CoV-2 strains
severe acute respiratory syndrome Coronavirus
suppressed
the SARS-CoV-2
therapeutic
translation
triggers
Vaccine
vector
vectors
viral adaptation
Viral load
viral loads
virus
wild-type
[DOI] 10.1016/j.ymthe.2022.01.024 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ymthe.2022.01.024 PMC 바로가기 [Article Type] Article